Navigation Links
Soligenix Receives $574,000 in Non-Dilutive Financing from New Jersey's Technology Business Tax Certificate Transfer Program
Date:1/26/2012

ance, prospects and opportunities. Statements that are not historical facts, such as "anticipate," "expect," "believe," "intend," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec®, SGX201, SGX202, SGX203, SGX204, RiVax™, and LPM™, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will not exceed projected levels, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the US Government or other countries, that the US Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business strategy will be successful. Important factors which may affect the future use of orBec® for gastrointestinal GVHD include the Data Safety Monitoring Board's recent determination disclosed in our Form 8-K dated September 15, 2011 recommending that Soligenix stop its confirmatory Phase 3 clinical trial of orB
'/>"/>
SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Soligenix Initiates Next Generation Anthrax Vaccine Development Program Under Agreement With Harvard University
2. Soligenix Reports Third Quarter 2011 Financial Results
3. Soligenix Announces Formation of Pediatric Crohns Disease Medical Advisory Board
4. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
5. Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
6. Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe
7. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
8. Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
9. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
10. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
11. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... IRVINE, Calif. , Oct 22, 2014 ... Irvine, California , announced the receipt ... Small Business Innovation Research award (SBIR) from the National Institute of ... will fund the development of a Pan-HIV Protein Microarray ... the HIV-1 and HIV-2 subtypes and aid in the ...
(Date:10/22/2014)... , Oct. 22, 2014 Moms are ... health trackers for themselves and their kids, according to ... Report: Health & Fitness Go Mobile for Moms, the ... Series. BabyCenter, the number 1 pregnancy and parenting web ... that 55 percent of moms surveyed say they can,t ...
(Date:10/22/2014)... PORTLAND, Oregon , October 22, 2014 ... titled, "Global Disposable Gloves Market (Product type, Form, End ... Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation ... the global disposable gloves market. Based on key trends ... to be valued at $7.9 billion by 2020, registering ...
Breaking Medicine Technology:Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4
(Date:10/25/2014)... safe and sound is one of the best Halloween treats ... and goody bags have reflective strips that improve visibility to ... Meadowlands Hospital Medical Center in Secaucus, N.J. Trick-or-treaters ... Davis said. He offers these others tips: ... small area of skin first to ensure it doesn,t cause ...
(Date:10/25/2014)... WI (PRWEB) October 25, 2014 ... tax-advantaged medical and other benefits account management services, ... to help employers save on taxes, reduce administrative ... Suites provide tax savings and the efficient handling ... pick the Suite that best meets their goals ...
(Date:10/25/2014)... QueenBeeTickets.com has a variety of tickets for ... prices. Bob Seger & The Silver Bullet Band tickets ... are going on sale October 25 and are expected ... browse the selection of tickets for Bob Seger & ... singer is touring North America beginning next month, and ...
(Date:10/25/2014)... Mesothelioma researchers are reporting extended survival in a ... his combination drug therapy became too toxic. Click ... on the Surviving Mesothelioma website. , A new ... suggests that “maintenance therapy” with pemetrexed may be the ... higher doses of cisplatin. , “Although the standard ...
(Date:10/25/2014)... Steven Reinberg HealthDay Reporter ... causes common cold sores -- herpes simplex -- might increase ... suggest. In fact, being a carrier of certain antibodies ... the researchers found. "The identification of a treatable ... a breakthrough," said lead researcher Dr. Hugo Lovheim, an associate ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3
... central government is supporting a programme named the "golden ... validate medicine protocols //for the global market.These are the ... of Medical Research and the Department of Indian System ... that the market for plant medicines would be worth ...
... Fibrosis is a rare genetic disorder, usually diagnosed in ... mucus to become thick, dry and sticky. //The mucus ... and other organs in the body. ,There ... disease varies from person to person and generally focuses ...
... afflicting the older population its possible to drive safely ... ,According to the latest edition of Harvard Men's Health ... increase the risk for auto accidents. Even normal, healthy ... reaction time, and sensory abilities. But simple preparations and ...
... Research by the scientists from Johns Hopkins had found that ... are the ones who follow all the advice of their ... ,In a national survey of more than 5,000 Americans, those ... medical encounter were more likely to report higher levels of ...
... The problem of child obesity is severe like never before. ... believe as a study from Tufts University this month proves, ... prologue. // ,''It's quite astounding -- this shows ... Boston Medical Center nutrition specialist involved with the initiative that ...
... the incidence of breast cancer is rapidly increasing in urban ... number one cancer in our major metros according to a ... ,The number of breast cancer cases is estimated to have ... marriage and delayed motherhood are some factors that can lead ...
Cached Medicine News:Health News:Early Awareness About Weight Management Needed To Tackle Lifelong Obesity 2
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
For the quantitative in vitro determination of Uric Acid in serum, plasma and urine...
The BUN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of urea nitrogen in serum, plasma and urine....
Medicine Products: